Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Carcinogenicity testing -- Congresses. : Safety evaluation of certain food additives / prepared by the fifty-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)
1999
1
Carcinogenicity testing -- Evaluation -- Congresses. : Long-term and short-term screening assays for carcinogens : a critical appraisal : reports of IARC ad hoc Working Groups which met in Hanover, F.R.G., 7-9 June, 1979, at a meeting organized by the Medizinische Hochschule Hanover, the Commission of the European Communities and the IARC
Carcinogens -- Standards -- Australia. : Control of workplace hazardous substances. Part 2, Scheduled carcinogenic substances : national model regulations for the control of scheduled carcinogenic substances (NOHSC:1011 (1995)) : national code of practice for the control of scheduled carcinogenic substances (NOHSC:2014(1995)) / National Occupational Health and Safety Commission
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer."
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma